Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 12

1.

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging.

Tsoukalas C, Laurent G, Jiménez Sánchez G, Tsotakos T, Bazzi R, Stellas D, Anagnostopoulos C, Moulopoulos L, Koutoulidis V, Paravatou-Petsotas M, Xanthopoulos S, Roux S, Bouziotis P.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A89. doi: 10.1186/2197-7364-2-S1-A89. No abstract available.

2.

Benzo[a]pyrene-induced cell cycle arrest in HepG2 cells is associated with delayed induction of mitotic instability.

Stellas D, Souliotis VL, Bekyrou M, Smirlis D, Kirsch-Volders M, Degrassi F, Cundari E, Kyrtopoulos SA.

Mutat Res. 2014 Nov;769:59-68. doi: 10.1016/j.mrfmmm.2014.07.004. Epub 2014 Jul 19.

PMID:
25771725
3.

Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.

Truillet C, Bouziotis P, Tsoukalas C, Brugière J, Martini M, Sancey L, Brichart T, Denat F, Boschetti F, Darbost U, Bonnamour I, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Perriat P, Lux F, Tillement O.

Contrast Media Mol Imaging. 2015 Jul-Aug;10(4):309-19. doi: 10.1002/cmmi.1633. Epub 2014 Dec 5.

PMID:
25483609
4.

Two novel compounds of vanadium and molybdenum with carnitine exhibiting potential pharmacological use.

Galani A, Tsitsias V, Stellas D, Psycharis V, Raptopoulou CP, Karaliota A.

J Inorg Biochem. 2014 Oct 22;142C:109-117. doi: 10.1016/j.jinorgbio.2014.10.004. [Epub ahead of print]

PMID:
25450025
5.

Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.

Stellas D, Szabolcs M, Koul S, Li Z, Polyzos A, Anagnostopoulos C, Cournia Z, Tamvakopoulos C, Klinakis A, Efstratiadis A.

J Natl Cancer Inst. 2014 Oct 11;106(12). pii: dju320. doi: 10.1093/jnci/dju320. Print 2014 Dec.

6.

Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detection.

Truillet C, Bouziotis P, Tsoukalas C, Sancey L, Denat F, Boschetti F, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Lux F, Perriat P, Tillement O.

EJNMMI Phys. 2014 Jul;1(Suppl 1):A80. doi: 10.1186/2197-7364-1-S1-A80. No abstract available.

7.

VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress.

Karali E, Bellou S, Stellas D, Klinakis A, Murphy C, Fotsis T.

Mol Cell. 2014 May 22;54(4):559-72. doi: 10.1016/j.molcel.2014.03.022. Epub 2014 Apr 17.

8.

Prox1 suppresses the proliferation of neuroblastoma cells via a dual action in p27-Kip1 and Cdc25A.

Foskolou IP, Stellas D, Rozani I, Lavigne MD, Politis PK.

Oncogene. 2013 Feb 21;32(8):947-60. doi: 10.1038/onc.2012.129. Epub 2012 Apr 16.

PMID:
22508481
9.

Inhibiting matrix metalloproteinases, an old story with new potentials for cancer treatment.

Stellas D, Patsavoudi E.

Anticancer Agents Med Chem. 2012 Sep;12(7):707-17. Review.

PMID:
22292747
11.

A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.

Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E.

J Biol Chem. 2008 Jan 25;283(4):2031-41. Epub 2007 Dec 5.

12.

Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis.

Stellas D, Karameris A, Patsavoudi E.

Clin Cancer Res. 2007 Mar 15;13(6):1831-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk